NP / PA
Dobson, Erin
Dobson, Erin was paid $365K by Medicaid between Apr 2019 and May 2024, across 19 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 27% of everything it billed.
33Billing provider infoDOBSON, ERIN
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1023230554assigned 05/03/2007
33bProvider typeNurse Practitioner
28Total paid$365K
24GClaims6,958
24DCodes billed19
24AFirst – last monthApr 2019 – May 2024
Compared with peers
Next to other Nurse Practitioner providers in Rhode Island
Rank by total paid#4 of 110
Median peer was paid$14K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 99 | $1K | |
| 2020 | 1,352 | $45K | |
| 2021 | 2,356 | $114K | |
| 2022 | 1,601 | $101K | |
| 2023 | 1,080 | $73K | |
| 2024incomplete | 470 | $32K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 27% | 647 | 628 | $97K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 21% | 645 | 626 | $75K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 17% | 2,059 | 1,618 | $62K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.7% | 505 | 457 | $32K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.1% | 182 | 126 | $26K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6.5% | 294 | 284 | $24K |
| 86780 | 4.0% | 290 | 279 | $15K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 205 | 196 | $8K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.2% | 110 | 106 | $8K |
| 86803 | 1.4% | 57 | 54 | $5K | |
| 87660 | 1.1% | 58 | 56 | $4K | |
| 87340 | <1% | 58 | 55 | $4K |
7 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 55 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 27 | $2K |
| 87210 | <1% | 45 | $953.50 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $335.88 |
| 3078F | <1% | 982 | $5.20 | |
| 1036F | <1% | 248 | $0.99 | |
| 3074F | <1% | 479 | $0.28 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.